Skip to main content

Advertisement

Springer Nature Link
Log in

Rethinking evaluation for multi-label drug-drug interaction prediction

  • Letter
  • Published:
Frontiers of Computer Science Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kantor E D, Rehm C D, Haas J S, Chan A T, Giovannucci E L. Trends in prescription drug use among adults in the United States from 1999–2012. JAMA, 2015, 314(17): 1818–1830

    Article  Google Scholar 

  2. Marengoni A, Pasina L, Concoreggi C, Martini G, Brognoli F, Nobili A, Onder G, Bettoni D. Understanding adverse drug reactions in older adults through drug–drug interactions. European Journal of Internal Medicine, 2014, 25(9): 843–846

    Article  Google Scholar 

  3. Zhao H, Zhong J, Liang X, Xie C, Wang S. Application of machine learning in drug side effect prediction: databases, methods, and challenges. Frontiers of Computer Science, 2025, 19(5): 195902

    Article  MATH  Google Scholar 

  4. Karim R, Cochez M, Jares J B, Uddin M, Beyan O, Decker S. Drug-drug interaction prediction based on knowledge graph embeddings and convolutional-LSTM network. In: Proceedings of the 10th ACM International Conference on Bioinformatics, Computational Biology and Health Informatics. 2019, 113–123

    Chapter  MATH  Google Scholar 

  5. Huang K, Xiao C, Glass L M, Zitnik M, Sun J. SkipGNN: predicting molecular interactions with skip-graph networks. Scientific Reports, 2020, 10(1): 21092

    Article  Google Scholar 

  6. Zitnik M, Agrawal M, Leskovec J. Modeling polypharmacy side effects with graph convolutional networks. Bioinformatics, 2018, 34(13): i457–i466

    Article  MATH  Google Scholar 

  7. Yu Y, Huang K, Zhang C, Glass L M, Sun J, Xiao C. SumGNN: multi-typed drug interaction prediction via efficient knowledge graph summarization. Bioinformatics, 2021, 37(18): 2988–2995

    Article  Google Scholar 

  8. Wang Y, Yang Z, Yao Q. Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning. Communications Medicine, 2024, 4(1): 59

    Article  MATH  Google Scholar 

  9. Zhang Y, Yao Q, Yue L, Wu X, Zhang Z, Lin Z, Zheng Y. Emerging drug interaction prediction enabled by a flow-based graph neural network with biomedical network. Nature Computational Science, 2023, 3(12): 1023–1033

    Article  MATH  Google Scholar 

Download references

Acknowledegments

This research was supported by the Key Program of Jiangsu Science Foundation (BK20243012) and the Fundamental Research Funds for the Central Universities (022114380023).

Author information

Authors and Affiliations

  1. National Key Laboratory for Novel Software Technology, Nanjing University, Nanjing, 210023, China

    Shi-Yu Tian, Zhi Zhou & Yu-Feng Li

  2. School of Artificial Intelligence, Nanjing University, Nanjing, 210023, China

    Shi-Yu Tian & Yu-Feng Li

  3. Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210023, China

    Xin Su

Authors
  1. Shi-Yu Tian
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Zhi Zhou
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Xin Su
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Yu-Feng Li
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Yu-Feng Li.

Ethics declarations

Competing interests The authors declare that they have no competing interests or financial conflicts to disclose.

Electronic Supplementary Material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tian, SY., Zhou, Z., Su, X. et al. Rethinking evaluation for multi-label drug-drug interaction prediction. Front. Comput. Sci. 19, 199358 (2025). https://doi.org/10.1007/s11704-024-41055-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11704-024-41055-9